# Multihance at 3 Tesla (3T) in Brain Tumors

> **NCT00395863** · PHASE4 · COMPLETED · sponsor: **Bracco Diagnostics, Inc** · enrollment: 46 (actual)

## Conditions studied

- Brain Tumor

## Interventions

- **DRUG:** Multihance
- **DRUG:** Arm 2 - Magnevist

## Key facts

- **NCT ID:** NCT00395863
- **Lead sponsor:** Bracco Diagnostics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-02
- **Final completion:** 2008-03
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2020-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00395863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00395863, "Multihance at 3 Tesla (3T) in Brain Tumors". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00395863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*